![Stefan Sperl](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stefan Sperl
Directeur des opérations chez
KIORA PHARMACEUTICALS, INC.
Profil
Stefan Sperl was the founder of Panoptes Pharma GmbH, founded in 2013, holding the title of Chief Operating Officer.
Dr. Sperl is currently the Executive Vice President-CMC & Operations at Kiora Pharmaceuticals, Inc. Formerly, Project Manager at Nabriva Therapeutics GmbH.
Education includes a doctorate from Max Planck Institute of Biochemistry.
Postes actifs de Stefan Sperl
| Sociétés | Poste | Début |
|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Directeur des opérations | - |
Anciens postes connus de Stefan Sperl
| Sociétés | Poste | Fin |
|---|---|---|
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research and development services | Corporate Officer/Principal | - |
Panoptes Pharma GmbH
 Panoptes Pharma GmbH BiotechnologyHealth Technology Develops molecule drugs to treat eye diseases | Fondateur | - |
Formation de Stefan Sperl
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
1
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Kiora Pharmaceuticals, Inc.
 Kiora Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for the treatment of ophthalmic diseases | Health Technology |
Nabriva Therapeutics GmbH
Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research and development services | Health Technology |
Max Planck Institute of Biochemistry
 Max Planck Institute of Biochemistry Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Panoptes Pharma GmbH
Panoptes Pharma GmbH BiotechnologyHealth Technology Develops molecule drugs to treat eye diseases | Health Technology |
